Current applications of transcatheter edge-to-edge tricuspid valve repair
10.3969/j.issn.1004-8812.2024.01.009
- VernacularTitle:经导管三尖瓣缘对缘修复术的应用现状
- Author:
Chun-Mei XIE
1
;
Meng-Qi SHEN
;
Da ZHU
;
Shou-Zheng WANG
;
Zhi-Ling LUO
;
Xiang-Bin PAN
Author Information
1. 云南省阜外心血管病医院 昆明医科大学附属心血管医院麻醉科,云南昆明 650102
- Keywords:
Tricuspid regurgitation;
Transcatheter edge-to-edge tricuspid valve repair;
Interventional therapy
- From:
Chinese Journal of Interventional Cardiology
2024;32(1):45-50
- CountryChina
- Language:Chinese
-
Abstract:
Tricuspid regurgitation(TR)is a common heart valve disease.According to the pathogenesis,TR can be divided into primary(organic)and secondary(functional)regurgitation,of which functional TR accounts for more than 90%.Patients with severe TR have poor prognosis and poor drug treatment,and surgery(valvuloplasty)is the main treatment.At present,transcatheter edge-to-edge tricuspid valve repair(T-TEER)has become an essential program of transcatheter treatment for TR,providing minimally invasive treatment for TR patients who cannot undergo surgery or are at high risk of surgery.T-TEER reduces the degree of regurgitation by clamping leaflets,and is currently in the early stage of research and development exploration and clinical validation,mainly for functional TR.T-TEER devices have also made significant progress(TriClip,PASCAL),and Chinese-made novel-designed T-TEER devices are also undergoing clinical trials(DragonFly-TTM,SQ-Kyrin-TTM,NeoBlazarTM).This paper reviews the current applications and research progress of T-TEER.
